Press Releases Simulations Plus, Inc.

Equities

SLP

US8292141053

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
45.45 ^USD	+1.70%		-1.20%	+1.56%

Apr. 17	InnoGI Technologies and Simulations Plus Combine Forces to Offer Next-Level Modeling Solutions for the Prediction of Oral Drug Performance	CI
Apr. 04	Sector Update: Health Care Stocks Slump Late Afternoon	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Simulations Plus, Inc. - U.S. FDA Renews DILIsym Software Licenses for 7th Year	Apr. 05	AQ
Simulations plus Reports Second Quarter Fiscal 2024 Financial Results	Apr. 05	AQ
U.S. FDA Renews DILIsym Software Licenses for 7th Year	Apr. 05	AQ
U.S. FDA Renews DILIsym® Software Licenses for 7th Year	Apr. 04	BU
Simulations Plus Reports Second Quarter Fiscal 2024 Financial Results	Apr. 03	BU
Simulations Plus: Fiscal Q2 Earnings Snapshot	Apr. 03	AQ
Simulations Plus Announces Second Quarter Fiscal Year 2024 Earnings and Conference Call Date	Mar. 20	BU
Simulations Plus : Lunch & Learn – SOT 63rd Annual Meeting and ToxExpo	Mar. 15	PU
Simulations Plus to Present at the KeyBanc Capital Markets Virtual Life Sciences and MedTech Investor Forum	Mar. 14	AQ
Simulations Plus to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum	Mar. 13	BU
Simulations Plus and the University of Bath Awarded New FDA Grant	Mar. 05	BU
Simulations Plus Extends Collaboration with Major Toxicology Research Agency	Feb. 15	BU
Simulations Plus Launches Corporate Development Initiative	Feb. 13	BU
Simulations Plus to Participate in Upcoming Healthcare Conferences	Feb. 06	BU
Simulations Plus Releases GastroPlus Version 9.9	Jan. 31	AQ
Simulations Plus Releases GastroPlus® Version 9.9	Jan. 30	BU
Simulations Plus Embarks on Collaboration with Northeastern University and The TIM Company Through New FDA Grant	Jan. 09	BU
Simulations Plus: Fiscal Q1 Earnings Snapshot	Jan. 03	AQ
Simulations Plus Announces Leadership Appointments Supporting Commitment to Clients and Driving Growth	Jan. 03	BU
Simulations Plus Reports First Quarter Fiscal 2024 Financial Results	Jan. 03	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Simulations Plus, Inc.

Equities

SLP

US8292141053

Press Releases

Filters